Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.45B | $24.88B | $23.20B | $20.75B | $19.63B | $17.86B | $21.39B | $21.61B | $20.40B | $19.75B | $0 | $0 | $0 | $0 | $0 | $13.71B |
| Research & development | $797.0M | $794.0M | $754.0M | $665.0M | $616.0M | $551.0M | $606.0M | $584.0M | $584.0M | $587.0M | $625.0M | $647.0M | $644.0M | $439.0M | $417.0M | $425.0M |
| Operating income | — | — | — | — | — | — | $3.67B | $3.63B | $3.21B | $2.96B | $3.13B | $3.31B | $3.18B | $2.22B | $2.26B | $1.70B |
| EBITDAderived | — | — | — | — | — | — | $4.56B | $4.53B | $4.13B | $3.89B | $4.06B | $4.29B | $4.17B | $2.81B | $2.82B | $2.25B |
| Net income | $4.09B | $3.79B | $3.22B | $2.46B | $2.14B | $1.41B | $2.21B | $2.15B | $2.99B | $1.92B | $1.97B | $1.80B | $1.87B | $1.22B | $1.35B | $929.0M |
| Basic EPSper diluted share | $10.48 | $9.54 | $8.06 | $6.17 | $5.38 | $3.51 | $5.28 | $4.93 | $6.71 | $4.21 | $4.23 | $3.78 | $3.93 | $3.54 | $3.98 | $2.76 |
| Diluted EPSper diluted share | $10.45 | $9.50 | $8.02 | $6.14 | $5.34 | $3.49 | $5.25 | $4.91 | $6.68 | $4.20 | $4.22 | $3.76 | $3.90 | $3.46 | $3.93 | $2.73 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 22, 2026Form 4 | Thompson Dorothy CDirector | SellOrdinary Shares | 167 | $385.00 | $64.3K | 1.1K |
| May 13, 2026Form 4 | Galvao AntonioSee Remarks below. | SellOrdinary Shares | 494 | $405.86 | $200.5K | 9.2K |
| May 11, 2026Form 4 | Johnson GeraldDirector | BuyOrdinary Shares | 215 | $419.02 | $90.1K | 1.6K |
| May 8, 2026Form 4 | Johnson GeraldDirector | BuyOrdinary Shares | 746 | $402.29 | $300.1K | 1.4K |
| May 6, 2026Form 4 | Monesmith Heath B.See Remarks below. | SellOrdinary Shares | 18.4K | $409.11 | $7.51M | 49.8K |